Gene · 6613
Papers2,290
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,290
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Positive feedback between ROS and cis-axis of PIASxα/p38α-SUMOylation/MK2 facilitates gastric cancer metastasis. | Cell Death Dis | 2021 | 34686655 | PubTator, text mining | PubMed |
| Identification of SUMO Targets Associated With the Pluripotent State in Human Stem Cells. | Mol Cell Proteomics | 2021 | 34673284 | PubTator, text mining | PubMed |
| Post-Translational Modifications of PCNA in Control of DNA Synthesis and DNA Damage Tolerance-the Implications in Carcinogenesis. | Int J Biol Sci | 2021 | 34671219 | PubTator, text mining | PubMed |
| Global SUMOylome Adjustments in Basal Defenses of Arabidopsis thaliana Involve Complex Interplay Between SMALL-UBIQUITIN LIKE MODIFIERs and the Negative Immune Regulator SUPPRESSOR OF rps4-RLD1. | Front Cell Dev Biol | 2021 | 34660568 | PubTator, text mining | PubMed |
| Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders. | Front Endocrinol (Lausanne) | 2021 | 34646233 | PubTator, text mining | PubMed |
| Cyclic CMP and cyclic UMP mediate bacterial immunity against phages. | Cell | 2021 | 34644530 | PubTator, text mining | PubMed |
| Ubiquitination and degradation of SUMO1 by small-molecule degraders extends survival of mice with patient-derived tumors. | Sci Transl Med | 2021 | 34644148 | PubTator, text mining | PubMed |
| A Different View for an Old Disease: NEDDylation and Other Ubiquitin-Like Post-Translational Modifications in Chronic Lymphocytic Leukemia. | Front Oncol | 2021 | 34631557 | PubTator, text mining | PubMed |
| SALL1 Modulates CBX4 Stability, Nuclear Bodies, and Regulation of Target Genes. | Front Cell Dev Biol | 2021 | 34621739 | PubTator, text mining | PubMed |
| Retraction: Silencing SUMO2 promotes protection against degradation and apoptosis of nucleus pulposus cells through p53 signaling pathway in intervertebral disc degeneration. | Biosci Rep | 2021 | 34612481 | PubTator, text mining | PubMed |
| Identification of hub genes and candidate drugs in hepatocellular carcinoma by integrated bioinformatics analysis. | Medicine (Baltimore) | 2021 | 34596112 | PubTator, text mining | PubMed |
| Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders. | Antioxidants (Basel) | 2021 | 34573116 | PubTator, text mining | PubMed |
| Stress-Induced Epstein-Barr Virus Reactivation. | Biomolecules | 2021 | 34572593 | PubTator, text mining | PubMed |
| Alzheimer's Disease: A Molecular View of β-Amyloid Induced Morbific Events. | Biomedicines | 2021 | 34572312 | PubTator, text mining | PubMed |
| Metabolomic signature of amino acids in plasma of patients with non-segmental Vitiligo. | Metabolomics | 2021 | 34562159 | PubTator, text mining | PubMed |
| CAPN3: A muscle‑specific calpain with an important role in the pathogenesis of diseases (Review). | Int J Mol Med | 2021 | 34549305 | PubTator, text mining | PubMed |
| Bromodomain proteins: protectors against endogenous DNA damage and facilitators of genome integrity. | Exp Mol Med | 2021 | 34548613 | PubTator, text mining | PubMed |
| Hub Genes and Key Pathways of Intervertebral Disc Degeneration: Bioinformatics Analysis and Validation. | Biomed Res Int | 2021 | 34545328 | PubTator, text mining | PubMed |
| The Epstein-Barr virus deubiquitinating enzyme BPLF1 regulates the activity of topoisomerase II during productive infection. | PLoS Pathog | 2021 | 34543352 | PubTator, text mining | PubMed |
| A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity. | Front Cell Dev Biol | 2021 | 34513832 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6613/papers?page=27